ClinicalTrials.Veeva

Menu

Retrospective Study of Germ Cell Tumors of the Central Nervous System

B

Beijing Sanbo Brain Hospital

Status

Active, not recruiting

Conditions

Germ Cell Tumor of CNS

Study type

Observational

Funder types

Other

Identifiers

NCT05836701
CNS-GCT-R

Details and patient eligibility

About

Retrospectively analyzing the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the germ-cell tumors of central nervous system in a single center.

Full description

Clinical data of patients with germ-cell tumors of central nervous system who were treated in the Department of Neuro-oncology, Sanbo Brain Hospital Capital Medical University between January 2007 and December 2022 were retrospectively collected, and the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the disease were analyzed.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinically or pathologically diagnosed as germ cell tumor of the central nervous system.
  • Have received antitumor therapy.
  • Patients who were clinically diagnosed based on neuroimaging characteristics and response to radiotherapy or chemotherapy were allowed for enrollment.

Exclusion criteria

  • Patients with missing key information such as tumor location, surgical, chemotherapy and radiotherapy data, and post-treatment evaluation.

Trial contacts and locations

1

Loading...

Central trial contact

Jun-ping Zhang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems